Article Details
Retrieved on: 2022-04-14 21:46:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The investigational drug masitinib appears to inhibit parts of the immune system that may be overactive in ALS. Peter King, M.D., professor of ...
Article found on: www.uab.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here